Top Stories

AlloSource Announces Bob Lay As Chief Operating Officer
Biologics Top Stories

AlloSource Announces Bob Lay As Chief Operating Officer

CENTENNIAL, Colo., Nov. 7, 2017 /PRNewswire-USNewswire/ — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Bob Lay as Chief Operating Officer. With over 20 years of experience in both finance and […]

OrthoPediatrics Could Win By Tapping A Massive, Underserved Market, Says Stifel
Financial Top Stories

OrthoPediatrics Could Win By Tapping A Massive, Underserved Market, Says Stifel

Shanthi Rexaline , Benzinga Staff Writer /November 6, 2017 Orthopediatrics Corp KIDS 4.9% is poised to achieve strong top-line growth due to its exclusive focus on the sizeable and largely underserved $2.5 billion pediatric orthopedic market, according to Stifel. Stifel initiated coverage of Orthopediatrics with a Buy rating and a $23 price target […]

Hologic to retain CEO MacMillan | Personnel Moves – November 3, 2017
Financial Top Stories

Hologic to retain CEO MacMillan | Personnel Moves – November 3, 2017

NOVEMBER 3, 2017/ BY FINK DENSFORD Hologic (NSDQ:HOLX) said this week its current prez and CEO Stephen MacMillan will stay on with the company, resolving rumors that he may depart it to take up the corner office at Zimmer Biomet (NYSE:ZBH). In an SEC filing, the Marlborough, Mass.-based company’s board said it approved a special “performance-based […]

Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation
Financial Top Stories

Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation

COLUMBIA, Md., Nov. 02, 2017 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (OTC Pink:OSIR) (the “Company”), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, today announced the resolution of the previously disclosed investigation by the Securities and Exchange Commission (the “SEC”) into the Company’s historical accounting practices. […]

Medacta Announces FDA Clearance and First Surgeries Utilizing 3DMetalTM Tibial Cones for Knee Revision
Recon Top Stories

Medacta Announces FDA Clearance and First Surgeries Utilizing 3DMetalTM Tibial Cones for Knee Revision

November 03, 2017 CASTEL SAN PIETRO, Switzerland–(BUSINESS WIRE)–Family-owned orthopedics leader Medacta International today announced the first surgeries utilizing its recently FDA-cleared 3DMetalTM Tibial Cones for knee revision surgery. The 3DMetal Tibial Cones can be used for structural support in areas of bone deficiencies that may compromise revision implant fixation, and are […]

SeaSpine Announces Limited Commercial Launch of OsteoStrand™ Demineralized Bone Fibers
Biologics Spine Top Stories

SeaSpine Announces Limited Commercial Launch of OsteoStrand™ Demineralized Bone Fibers

CARLSBAD, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of initial surgeries for its OsteoStrand™ Demineralized Bone Fibers. The first implantations were completed by […]

Corin completes Joint Venture Agreement with Ossis to deliver life-changing personalised reconstructive solutions
Recon Top Stories

Corin completes Joint Venture Agreement with Ossis to deliver life-changing personalised reconstructive solutions

Corin, a global orthopaedic manufacturer and leader in functional implant positioning has announced a joint venture agreement with Ossis, a New Zealand-based implant maker. With more than 15 years clinical history Ossis is one of the leaders in design and manufacturing of personalised solutions for complex revision surgery and tumour […]

Consensus Orthopedics launches TracPatch Australia at the Australian AOA meeting in partnership with CUER
Sports Medicine Top Stories

Consensus Orthopedics launches TracPatch Australia at the Australian AOA meeting in partnership with CUER

SACRAMENTO, CALIF. (PRWEB) NOVEMBER 01, 2017 Consensus Orthopedics, developer of the latest wearable technology, TracPatch™, has partnered with Neil Thomas and Peter Mackie of CUER, who have come together to cofound TracPatch Australia to distribute this wearable technology throughout Australia and New Zealand. The Australian market is in need of a device […]

Intellijoint Surgical Inc. Receives FDA Clearance for Revision THA with intellijoint HIP®
Recon Regulatory Top Stories

Intellijoint Surgical Inc. Receives FDA Clearance for Revision THA with intellijoint HIP®

WATERLOO, ON, Nov. 1, 2017 /PRNewswire/ – Intellijoint Surgical®, a medical technology company, is pleased to announce that it has received FDA Clearance for revision Total Hip Arthroplasty (THA) with its intellijoint HIP® System. A 3D Mini-Optical Navigation System, intellijoint HIP® provides surgeons with precise measurements for cup position, leg length and offset for THA. Requiring […]

MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions
Biologics Regulatory Top Stories

MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions

MARIETTA, Ga., Nov. 1, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today that the Company has agreed to a confidential settlement of the lawsuit the Company […]

ECA Medical Instruments Launches Cervical-One™ Sterile-Packed, Disposable Instrument Kit for One & Two-Level Fusions
Spine Top Stories

ECA Medical Instruments Launches Cervical-One™ Sterile-Packed, Disposable Instrument Kit for One & Two-Level Fusions

November 1, 2017 Thousand Oaks, CA.—ECA Medical Instruments, the leading designer and manufacturer of single-procedure torque-limiting instruments and surgery-ready procedural kits for the medical industry and surgeons worldwide, has launched the Cervical-One™ single-procedure instrument set for use in one and two-level cervical spine implant procedures.  The novel instrument set is […]

Atlas Spine, Inc., Announces FDA 510(k) Clearance on Ortus Expandable Posterior Lumbar Interbody System
Spine Top Stories

Atlas Spine, Inc., Announces FDA 510(k) Clearance on Ortus Expandable Posterior Lumbar Interbody System

Jupiter, Florida., October 31, 2017 (PR NEWSWIRE) — Atlas Spine, Inc., a high technology, spinal implant and instrumentation company based in Jupiter, Florida, today announced that the Ortus™ Expandable Posterior Lumbar Interbody System has been 510(k) cleared by the U.S. Food and Drug Administration (FDA). The device is designed to […]

OMNIlife science™, Inc. Announces First Clinical Evaluations of Revolutionary OMNIBotics® Active Spacer Robotic Tissue Balancing Device
Recon Robotics Top Stories

OMNIlife science™, Inc. Announces First Clinical Evaluations of Revolutionary OMNIBotics® Active Spacer Robotic Tissue Balancing Device

RAYNHAM, Mass., Oct. 31, 2017 /PRNewswire/ — OMNIlife science, Inc. (“OMNI™”), a privately-held, established medical technology company targeting the $15 billion global hip and knee replacement device market, announced today that they have begun clinical evaluations of their exclusive OMNIBotics Active Spacer robotic tissue balancing device at three U.S. sites. This technology received 510(k) […]

Mizuho OSI® Introduces New Levó Head Positioning System for Spine Procedures
Spine Top Stories

Mizuho OSI® Introduces New Levó Head Positioning System for Spine Procedures

UNION CITY, Calif., Oct. 25, 2017 /PRNewswire/ — Mizuho OSI®, a leading manufacturer of specialty surgical tables, pressure management solutions, and table specific patient care kits, is introducing its newest technology, the Levó Head Positioning System at NASS 2017. Using an innovative electro-mechanical technology to enable the device’s motion, the Levó System introduces a […]

Cerapedics Announces i-FACTOR™ Peptide Enhanced Bone Graft Adopted by More than 150 Leading U.S. Hospitals
Biologics Top Stories

Cerapedics Announces i-FACTOR™ Peptide Enhanced Bone Graft Adopted by More than 150 Leading U.S. Hospitals

WESTMINSTER, Colo., Oct. 26, 2017 /PRNewswire/ — Cerapedics, a privately-held orthobiologics company, today announced that more than 150 leading U.S. hospitals have now adopted use of i-FACTOR™ Peptide Enhanced Bone Graft. Cerapedics received Premarket Approval (PMA) for i-FACTOR bone graft from the U.S. Food and Drug Administration (FDA) in late 2015 for use […]